Traders Purchase High Volume of SPDR S&P Biotech ETF Put Options (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of unusually large options trading on Wednesday. Traders acquired 71,998 put options on the company. This is an increase of 37% compared to the typical daily volume of 52,743 put options.

Institutional Trading of SPDR S&P Biotech ETF

Several hedge funds have recently bought and sold shares of XBI. JPMorgan Chase & Co. raised its holdings in SPDR S&P Biotech ETF by 27.3% during the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of SPDR S&P Biotech ETF by 33.0% during the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after acquiring an additional 3,353,029 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 9.3% in the 3rd quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after acquiring an additional 138,322 shares during the last quarter. Ameriprise Financial Inc. lifted its position in SPDR S&P Biotech ETF by 40.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after acquiring an additional 353,351 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in SPDR S&P Biotech ETF by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 819,267 shares of the exchange traded fund’s stock valued at $65,379,000 after acquiring an additional 21,804 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $118.46 on Wednesday. The stock has a market capitalization of $7.19 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $123.47. The stock has a 50 day moving average price of $109.84 and a two-hundred day moving average price of $94.95.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.